Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
Haematologica
|
March 13, 2025
Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial
Richard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.
Blood
|
January 1, 2015
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2006
Acute myeloid leukemia clinical practice guidelines in oncology
Margaret R O'Donnell, Frederick R Appelbaum, Maria R Baer, et al.
Haematologica
|
April 1, 2026
<i>Erratum</i> to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"
Richard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.
Biomarker Research
|
March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
Blood Advances
|
October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trial
Mark J Levis, Harry P Erba, Pau Montesinos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Hossein Borghaei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Acute myeloid leukemia
Margaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
Haematologica
|
March 13, 2025
Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial
Richard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.
Blood
|
January 1, 2015
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2006
Acute myeloid leukemia clinical practice guidelines in oncology
Margaret R O'Donnell, Frederick R Appelbaum, Maria R Baer, et al.
Haematologica
|
April 1, 2026
<i>Erratum</i> to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"
Richard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.
Biomarker Research
|
March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
Blood Advances
|
October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trial
Mark J Levis, Harry P Erba, Pau Montesinos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Hossein Borghaei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Acute myeloid leukemia
Margaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
Page
of 13